Bristol-Myers Squibb CompanyBMYNYSE
Loading
Book Value/Share Growth Under PressureDecelerating
Percentile Rank31
Year-over-Year Change
Year-over-year book value per share growth
Percentile
P31
Within normal range
vs 2Y Ago
-0.2x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -0.65% |
| Q3 2025 | 6.20% |
| Q2 2025 | 0.04% |
| Q1 2025 | 6.36% |
| Q4 2024 | -4.77% |
| Q3 2024 | 0.72% |
| Q2 2024 | 2.94% |
| Q1 2024 | -43.77% |
| Q4 2023 | 2.96% |
| Q3 2023 | -7.68% |
| Q2 2023 | 0.74% |
| Q1 2023 | 2.91% |
| Q4 2022 | -3.81% |
| Q3 2022 | 0.22% |
| Q2 2022 | 3.84% |
| Q1 2022 | -11.83% |
| Q4 2021 | -0.47% |
| Q3 2021 | 1.48% |
| Q2 2021 | -1.73% |
| Q1 2021 | 0.16% |
| Q4 2020 | -24.42% |
| Q3 2020 | 2.45% |
| Q2 2020 | -1.85% |
| Q1 2020 | -18.03% |
| Q4 2019 | 148.21% |
| Q3 2019 | 10.18% |
| Q2 2019 | 5.33% |
| Q1 2019 | 8.29% |
| Q4 2018 | 2.74% |
| Q3 2018 | 10.79% |
| Q2 2018 | -3.78% |
| Q1 2018 | 9.14% |
| Q4 2017 | -20.42% |
| Q3 2017 | 0.93% |
| Q2 2017 | 3.08% |
| Q1 2017 | -10.55% |
| Q4 2016 | 3.52% |
| Q3 2016 | 4.60% |
| Q2 2016 | 3.56% |
| Q1 2016 | -0.32% |